Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
83.67
-1.48 (-1.74%)
Aug 12, 2026, 10:20 AM EDT - Market open
Globus Medical Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Globus Medical stock has a consensus rating of "Buy" and an average price target of $103.23. The average 1-year stock price forecast is 23.38% higher than the current stock price, while the lowest is $84 (+0.39%) and the highest is $125 (+49.40%).
Price Target: $103.23 (+23.38%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Globus Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 6 | 6 | 7 | 7 |
| Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Hold | 4 | 4 | 4 | 4 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 13 | 13 | 13 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 7, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $115 | Buy | Maintains | $115 | +37.44% | Aug 7, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $80 → $85 | Hold | Maintains | $80 → $85 | +1.59% | Aug 7, 2026 |
| BMO Capital | BMO Capital | Buy Reiterates $94 | Buy | Reiterates | $94 | +12.35% | Aug 7, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $100 | Buy | Reiterates | $100 | +19.52% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
3.20B
from 2.94B
Increased by 8.87%
Revenue Next Year
3.39B
from 3.20B
Increased by 6.00%
EPS This Year
4.96
from 3.98
Increased by 24.73%
EPS Next Year
5.34
from 4.96
Increased by 7.47%
EPS and Forward PE are based on non-GAAP adjusted numbers.